BTTX

Better Therapeutics Inc

0.7115
0.0215 (3.12%)

Better Therapeutics Inc. (BTTX) Fundamentals

Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.
SHARE INFORMATION
Market Cap$ 21,894,430
Shares Outstanding31,731,352
Float3,230,000
Percent Float10.18%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.39
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions42
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months5,559
Institutional Holdings Percent12.9%
Institutional Sold Previous 3 Months253,317
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months256,900
Insider Holdings Percent0.6
Insider Sold Previous 3 Months-
Insider Shares Owned673,381
TRADING INFO
52 Week High$ 2.80
52 Week Low$ 0.59
52 Week High Change$ -67.76
21 Day Moving Average$ 0.8908
21 Day Extended Moving Average$ 0.872636
50 Day Moving Average$ 0.9955
50 Day Extended Moving Average$ 0.989355
200 Day Moving Average$ 1.3621
200 Day Extended Moving Average$ 1.5379
10 Day Average Volume135,868
20 Day Average Volume196,381
30 Day Average Volume177,177
50 Day Average Volume165,815
Alpha-0.041827
Beta1.5673
Standard Deviation0.329991
R20.066437
7 Day Price Change$ -0.0963
7 Day Percent Change-12.25%
21 Day Price Change$ -0.2868
21 Day Percent Change-29.36%
30 Day Price Change$ -0.54
30 Day Percent Change-43.9%
Month to Date Price Change$ -0.475
Month to Date Percent Change-40.77%
Quarter to Date Price Change$ -0.01
Quarter to Date Percent Change-1.43%
180 Day Price Change$ -0.725
180 Day Percent Change-51.24%
200 Day Price Change$ -0.76
200 Day Percent Change-52.41%
Year to Date Price Change$ -0.415
Year to Date Percent Change-37.56%

Better Therapeutics Inc. (BTTX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin-3,127,568.5%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-1.80
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio0.60
Leverage Ratio0.00
Quick Ratio0.40
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 34,183,915
Price to Sales0.00
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book-2.50
Price To Cash Flow-0.70
PE Low Last 5 Years0.00
Price to Tangible Book-1.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-148.61
Return on Equity-448.56
Return on Capital0.00

Better Therapeutics Inc. (BTTX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOFrank L. Karbe
Employees44
Last Audit-
CIK0001832415
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address548 Market Street,Suite 49404
Suite 49404
San Francisco, CA 94104
Websitehttps://www.bettertx.com
Facsimile-
Telephone+1 415 887-2311
Email-


Your Recent History
NASDAQ
BTTX
Better The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.